Shiladitya Sengupta - Concepedia

Author

Shiladitya Sengupta

Brigham and Women's Hospital ORCID

Also Known As

S Sengupta, S. K. Sengupta, S. Sengupta, Sengupta, S., Sengupta, Shiladitya, Shamik Ghosh, Shiladitya Sengupta

168

Publications

6.2K

Citations

H-Index

138

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Harvard–MIT Division of Health Sciences and Technology Dana-Farber Cancer Institute Massachusetts Institute of Technology

About

Shiladitya Sengupta is an author at Brigham and Women's Hospital specializing in medicine, nanomedicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	3.1K
2	Engineering	15	15	1.6K
3	Health Sciences	5	5	429
4	Natural Sciences	1	1	19
5	Anesthesia	1	1	23

Shiladitya Sengupta

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Shiladitya Sengupta, David A. Eavarone, Ishan Capila, Nature Tissue EngineeringNanomedicineNanoparticlesTemporal TargetingEngineering	2005	936
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells Tanmoy Saha, Chinmayee Dash, Ruparoshni Jayabalan, Nature Nanotechnology NanotherapeuticsMitochondrial FunctionCell TraffickingImmunologyCytoskeleton	2021	341
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity Biswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, Nature Communications Ex Vivo PlatformTumor BiologyComputational MedicineTumor HeterogeneityTumour Ecosystem	2015	298
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition Aaron Goldman, Biswanath Majumder, Andrew Dhawan, Nature Communications	2015	284
A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan, Nature Biomedical Engineering Cancer ImmunosurveillanceAggressive CancerImmunologyImmunoeditingTumor Targeting	2018	190
<i>EGLN1</i> involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda Shilpi Aggarwal, Sapna Negi, Pankaj Jha, Proceedings of the National Academy of Sciences	2010	170
Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype Marcelo Boareto, Mohit Kumar Jolly, Aaron Goldman, Journal of The Royal Society Interface	2016	145
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy Jeremy Baldwin, Christoph Heuser, Tanmoy Saha, Cell MitophagyMitochondrial FunctionAntitumor EfficacyCell BiologyMedicine	2024	144
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy Abhimanyu S. Paraskar, Shivani Soni, Kenneth T. Chin, Proceedings of the National Academy of Sciences	2010	130
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy Sudipta Basu, Rania Harfouche, Shivani Soni, Proceedings of the National Academy of Sciences NanomedicineDrug TargetingNanotherapeuticsPolymer-drug ConjugateMedicine	2009	129

Page 1